Literature DB >> 3746171

Phlegm production and lung function among cigarette smokers changing tar groups during the 1970s.

H Peach, D M Hayward, D R Ellard, R W Morris, D Shah.   

Abstract

In 1971-3 data on smoking habits, cigarette brand smoked, morning phlegm production, and lung function were recorded for factory workers as part of the Heart Disease Prevention Project. These men were reassessed in 1984 and those who had always smoked cigarettes from the same tar group were compared with those who had dropped one tar group (mean decreases of 6.6 mg tar, 0.1 mg nicotine) and two tar groups (mean decreases of 11.9 mg tar, 0.5 mg nicotine). Over the 13 years, men who had dropped one tar group were significantly more likely (p less than 0.05) to stop producing phlegm, but the effect was less marked for those who had dropped two tar groups. The mean fall in FEV1 was similar in all three groups, but 95% confidence limits showed that although dropping one tar group could be associated with at most a saving of 84 ml over the follow up period, there could be little extra benefit from dropping two tar groups. In 1984, all three groups of smokers excreted similar amounts of nicotine metabolites in the urine, suggesting that men who had dropped two tar groups compensated for the reduced nicotine yield of their cigarettes. This could account for the lack of a dose response relationship between reduction in the tar yield of cigarettes and cessation of phlegm and fall in FEV1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3746171      PMCID: PMC1052503          DOI: 10.1136/jech.40.2.110

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  11 in total

1.  Chronic nonspecific respiratory disease in Berlin, New Hampshire, 1967 to 1973. A further follow-up study.

Authors:  B G Ferris; H Chen; S Puleo; R L Murphy
Journal:  Am Rev Respir Dis       Date:  1976-04

2.  Urine tests to monitor the self-administration of dapsone by leprosy patients.

Authors:  G A Ellard; P T Gammon; H S Helmy; R J Rees
Journal:  Am J Trop Med Hyg       Date:  1974-05       Impact factor: 2.345

3.  Phlegm and filters.

Authors:  J Rimington
Journal:  Br Med J       Date:  1972-04-29

4.  Cigarette smoking and changes in respiratory findings.

Authors:  G W Comstock; W J Brownlow; R W Stone; P E Sartwell
Journal:  Arch Environ Health       Date:  1970-07

5.  Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked.

Authors:  T Higenbottam; T J Clark; M J Shipley; G Rose
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

6.  Smoking and health: the association between smoking behaviour, total mortality, and cardiorespiratory disease in west central Scotland.

Authors:  V M Hawthorne; J S Fry
Journal:  J Epidemiol Community Health (1978)       Date:  1978-12

7.  Changes of smoking habits and cough in men smoking cigarettes with 30% NSM tobacco substitute.

Authors:  S Freedman; C M Fletcher
Journal:  Br Med J       Date:  1976-06-12

8.  Heart disease prevention project: a randomised controlled trial in industry.

Authors:  G Rose; R F Heller; H T Pedoe; D G Christie
Journal:  Br Med J       Date:  1980-03-15

9.  Factors related to respiratory and cardiovascular symptoms in the United Kingdom.

Authors:  G Dean; P N Lee; G F Todd; A J Wicken; D N Sparks
Journal:  J Epidemiol Community Health (1978)       Date:  1978-06

10.  Smoking and lung function.

Authors:  G J Beck; C A Doyle; E N Schachter
Journal:  Am Rev Respir Dis       Date:  1981-02
View more
  3 in total

1.  Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence.

Authors:  M J Thun; D M Burns
Journal:  Tob Control       Date:  2001       Impact factor: 7.552

Review 2.  Systematic review of the evidence relating FEV1 decline to giving up smoking.

Authors:  Peter N Lee; John S Fry
Journal:  BMC Med       Date:  2010-12-14       Impact factor: 8.775

3.  Longitudinal study of long-term smoking behaviour by biomarker-supported determination of exposure to smoke.

Authors:  Anthony Cunningham; Johan Sommarström; Ajit S Sisodiya; Graham Errington; Krishna Prasad
Journal:  BMC Public Health       Date:  2014-04-12       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.